Hindustan Aarneel Clinical Labs Profile
Key Indicators
- Authorised Capital ₹ 5.32 Cr
as on 31-10-2024
- Paid Up Capital ₹ 5.27 Cr
as on 31-10-2024
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.49 Cr
as on 31-10-2024
About Hindustan Aarneel Clinical Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.32 Cr and a paid-up capital of Rs 5.27 Cr.
The company currently has active open charges totaling ₹15.49 Cr.
Debjyoti Roy, Siddharth Sangwan, and Anish Basral serve as directors at the Company.
- CIN/LLPIN
U85300MP2022PTC062553
- Company No.
062553
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2022
- Date of AGM
29 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hindustan Aarneel Clinical Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Sangwan  | Director | 05-Sep-2022 | Current |
| Debjyoti Roy | Director | 14-Jun-2023 | Current |
| Anish Basral | Director | 05-Sep-2022 | Current |
Financial Performance of Hindustan Aarneel Clinical Labs.
Hindustan Aarneel Clinical Labs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hindustan Aarneel Clinical Labs?
Unlock access to Hindustan Aarneel Clinical Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hwjhs Labs Private LimitedActive 2 years 3 monthsSiddharth Sangwan and Anish Basral are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Jan 2024 | ₹2.99 M | Open |
Others Creation Date: 16 Dec 2023 | ₹4.73 M | Open |
Others Creation Date: 19 Aug 2023 | ₹2.49 M | Open |
How Many Employees Work at Hindustan Aarneel Clinical Labs?
Hindustan Aarneel Clinical Labs has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hindustan Aarneel Clinical Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Aarneel Clinical Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
